CLASS II Device recall · Reported 1 Jun 2016 · FDA Enforcement Report

cobas¿ EGFR Mutation Test, v2 recalled by Roche Molecular Systems

Roche Molecular Systems is recalling cobas¿ EGFR Mutation Test, v2 and cobas¿ cfDNA Sample Preparation Hungarian Translation. The recall was initiated on 15 Mar 2016 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesEGFR v2: 07248563190 cfDNA: 07247737190
Quantity recalled8 kits

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1830-2016
FDA event ID
73703
Recalling firm
Roche Molecular Systems, Branchburg, NJ
Classification
Class II
Status
Terminated
Recall initiated
15 Mar 2016
FDA classified
26 May 2016
Reported
1 Jun 2016
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

15 Mar 2016Recall initiated by company
26 May 2016Classified by FDA+72 days
1 Jun 2016Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

An error was found within the Hungarian translations of the cobas¿ EGFR Mutation Test v2 Instructions for Use (M/N 07340761001-01HU, Doc Rev. 1.0, Dated 08/2015) and the cobas¿ cfDNA Sample Preparation Kit Instructions for Use (M/N 07573758001-01HU, Doc. Rev. 1.0, Dated 05/2015).

Product as listed by the FDA

cobas¿ EGFR Mutation Test, v2 and cobas¿ cfDNA Sample Preparation Hungarian Translation Instructions for Use

Where it was distributed

Hungary

Questions about this recall

Is cobas¿ EGFR Mutation Test, v2 and cobas¿ cfDNA Sample Preparation Hungarian Translation recalled?

Yes. Roche Molecular Systems recalled cobas¿ EGFR Mutation Test, v2 and cobas¿ cfDNA Sample Preparation Hungarian Translation on 15 Mar 2016. The recall is Class II and its status is Terminated. Recall number Z-1830-2016.

Why was it recalled?

An error was found within the Hungarian translations of the cobas¿ EGFR Mutation Test v2 Instructions for Use (M/N 07340761001-01HU, Doc Rev. 1.0, Dated 08/2015) and the cobas¿ cfDNA Sample Preparation Kit Instructions for Use (M/N 07573758001-01HU, Doc. Rev. 1.0, Dated 05/2015).

Which lots are affected?

EGFR v2: 07248563190 cfDNA: 07247737190

Where was it sold?

Hungary

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Roche Molecular Systems

All 42

Other Other Medical Devices recalls

All 13,778